Life Sciences Legal Insights

Insight and analysis on important legal issues affecting life sciences, mHealth, digital health and healthcare IT.

Latest from Life Sciences Legal Insights

  Last year the digital health sector smashed all previous records for both fundraising and consumer adoption of novel technologies. So far, 2021 is already on track to outshine last year’s impressive numbers. Digital health startups raised a record $6.7 billion, according to our good friends at Rock Health, up more than 100% from the $3.1 billion they collectively raised in the first quarter of 2020. There were 147 financings in Q1 2021, an…
Recently, my fellow corporate partner Allison Cooper moderated a webinar, “A Conversation with the Women Building Digital Health’s Future,” during which she had the privilege of interviewing three amazing women CEOs of fast-growing digital health companies: Vernita Brown, CEO of reproductive health technology company Natalist, Varsha Rao, CEO of prescription and delivery platform company NURX and Christine Lemke, co-founder and co-CEO of healthcare data company Evidation Health. The wide-ranging conversation included insights…
The life sciences sector will likely be one of the major drivers in what some analysts predict as the beginning of the largest economic expansion in recent history. Fenwick’s 2021 survey of 366 tech and life sciences executives and investors points to a post-pandemic IPO boom fueled in part by innovation related to the success of COVID-19 vaccine development. Startups working in technology and life sciences went public in record numbers during the second half…
Even with the COVID-19 vaccine rollout beginning to accelerate, for the majority of companies—those that aren’t taking the ‘virtual-only workforce’ leap—transitioning employees safely back into an office setting, even on a part-time basis, likely won’t happen for many months. However, there are steps companies should be taking now to prepare, and Fenwick has several resources available, highlighted here, for our clients and other friends. Staying informed of the latest news and the most recent guidance…
In prior years, it was almost a foregone conclusion that promising digital health startups would be acquired by other companies before having the opportunity to debut on the public markets. However, that changed in 2019, which was declared the “year of the digital health IPO.” The trend continued in 2020, even as the U.S. economy struggled to recover from the economic shock brought about by the COVID-19 pandemic. Six digital health companies took the traditional…
Digital health companies and investors had a remarkable 2020, as fundraising totals broke records and deal volume significantly outpaced previous years. Moreover, the increase in investment activity has triggered more exit opportunities, from IPOs to M&A deals. Among the most notable digital health transactions in 2020 was the $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo. The deal made waves across the industry not just because of its…
From the COVID-19 pandemic to a historic U.S. presidential election, 2020 will be remembered as the year the world turned upside down. It has also been an unprecedented year for digital health investors and companies in the sector, which have risen to meet the surge in demand for virtual care. 2020 was declared the largest funding year on record before the fourth quarter even began. It has also been a banner year for megadeals,…
When investors survey the digital health sector today, they see nearly every number trending upward. There is more deal volume than VCs have seen in past years, with the third quarter of 2020 outpacing anything they’ve seen in the past by double-digit percentages. There are more veteran healthcare investors making bets in digital health, and there are more newcomers with little to no prior healthcare experience jumping in with both feet. Investment activity by corporates…
Virtual healthcare staked out exciting new ground with the recently announced $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo. The deal illustrates the growing appetite among public-market investors for innovative healthcare solutions. Analysts at Rock Health likened the deal to a “starter pistol” that signals the beginning of a race—in this case, a race toward consolidation in a red-hot sector that has been maturing rapidly since the pandemic opened…
Venture investors are pleased to see digital health companies continue to transform the healthcare system despite unprecedented challenges brought by the COVID-19 pandemic. Funding for digital health startups broke records in the first half of 2020 as adoption of telemedicine and other remote programs spiked to meet the sudden surge in demand. But the future of digital health will be determined not just by consumers, technology developers and investors. Government agencies, insurers and public-market investors…